These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16581270)

  • 1. A novel approach to data processing of the QT interval response in the conscious telemetered beagle dog.
    Ollerstam A; Persson AH; Visser SA; Fredriksson JM; Forsberg T; Nilsson LB; Eklund G; Wiklund SJ; Gabrielsson J; Duker G; Al-Saffar A
    J Pharmacol Toxicol Methods; 2007; 55(1):35-48. PubMed ID: 16581270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs.
    Ollerstam A; Visser SA; Duker G; Forsberg T; Persson AH; Nilsson LB; Björkman JA; Gabrielsson J; Al-Saffar A
    J Pharmacol Toxicol Methods; 2007; 56(2):131-44. PubMed ID: 17689270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs.
    Ollerstam A; Visser SA; Persson AH; Eklund G; Nilsson LB; Forsberg T; Wiklund SJ; Gabrielsson J; Duker G; Al-Saffar A
    J Pharmacol Toxicol Methods; 2006; 53(2):174-83. PubMed ID: 16140023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.
    Nolan ER; Feng MR; Koup JR; Liu J; Turluck D; Zhang Y; Paulissen JB; Olivier NB; Miller T; Bailie MB
    J Pharmacol Toxicol Methods; 2006; 53(1):1-10. PubMed ID: 16399550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.
    Chaves AA; Zingaro GJ; Yordy MA; Bustard KA; O'Sullivan S; Galijatovic-Idrizbegovic A; Schuck H; Christian DB; Hoe CM; Briscoe RJ
    J Pharmacol Toxicol Methods; 2007; 56(2):103-14. PubMed ID: 17643323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculation of QT shift in non clinical safety pharmacology studies.
    Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
    J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.
    Markert M; Shen R; Trautmann T; Guth B
    J Pharmacol Toxicol Methods; 2011; 64(1):25-41. PubMed ID: 21635956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of drug-induced QT interval prolongation in conscious rabbits.
    Kijtawornrat A; Ozkanlar Y; Keene BW; Roche BM; Hamlin DM; Hamlin RL
    J Pharmacol Toxicol Methods; 2006; 53(2):168-73. PubMed ID: 16290300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization.
    Terrar DA; Wilson CM; Graham SG; Bryant SM; Heath BM
    J Pharmacol Toxicol Methods; 2007; 56(2):171-85. PubMed ID: 17596973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardiovascular and pharmacokinetic profile of dofetilide in conscious telemetered beagle dogs and cynomolgus monkeys.
    Haushalter TM; Friedrichs GS; Reynolds DL; Barecki-Roach M; Pastino G; Hayes R; Bass AS
    Br J Pharmacol; 2008 Aug; 154(7):1457-64. PubMed ID: 18604237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals.
    Toyoshima S; Kanno A; Kitayama T; Sekiya K; Nakai K; Haruna M; Mino T; Miyazaki H; Yano K; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):459-71. PubMed ID: 16493187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of blood pressure and electrocardiogram in conscious freely moving guineapigs: a model for screening QT interval prolongation effects.
    Hess P; Rey M; Wanner D; Steiner B; Clozel M
    Lab Anim; 2007 Oct; 41(4):470-80. PubMed ID: 17988441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment.
    Fossa AA; DePasquale MJ; Raunig DL; Avery MJ; Leishman DJ
    J Pharmacol Exp Ther; 2002 Aug; 302(2):828-33. PubMed ID: 12130750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: heart rate-dependent effects during sinus rhythm in conscious telemetered dogs.
    Sällström J; Al-Saffar A; Pehrson R
    J Pharmacol Toxicol Methods; 2014; 69(1):24-9. PubMed ID: 24140388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
    Tattersall ML; Dymond M; Hammond T; Valentin JP
    J Pharmacol Toxicol Methods; 2006; 53(1):11-9. PubMed ID: 15886026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational pharmacokinetic-pharmacodynamic modeling of QTc effects in dog and human.
    Parkinson J; Visser SA; Jarvis P; Pollard C; Valentin JP; Yates JW; Ewart L
    J Pharmacol Toxicol Methods; 2013; 68(3):357-66. PubMed ID: 23567074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical application of guinea pig telemetry system for QT evaluation.
    Shiotani M; Harada T; Abe J; Sawada Y; Hashimoto K; Hamada Y; Horii I
    J Toxicol Sci; 2005 Aug; 30(3):239-47. PubMed ID: 16141657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular monkey telemetry: sensitivity to detect QT interval prolongation.
    Chaves AA; Keller WJ; O'Sullivan S; Williams MA; Fitzgerald LE; McPherson HE; Goykhman D; Ward PD; Hoe CM; Mixson L; Briscoe RJ
    J Pharmacol Toxicol Methods; 2006; 54(2):150-8. PubMed ID: 16679034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferences of the autonomic nervous system with drug induced QT prolongation: a point to consider in non-clinical safety studies.
    Champeroux P; Ouillé A; Martel E; Fowler JS; Maurin A; Jude S; Lala P; Le Guennec JY; Richard S
    J Pharmacol Toxicol Methods; 2010; 61(3):251-63. PubMed ID: 20172034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs.
    Batey AJ; Doe CP
    J Pharmacol Toxicol Methods; 2002; 48(1):11-9. PubMed ID: 12750037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.